124 E 40th Street Suite 301, New York, NY 10016
Migraines can be debilitating for some. They incapacitate them to the point that they have to miss family events, cancel outings and recreational activities, and stay home from work. They must stay inside on a beautiful day, because the light from the sun exacerbates their pain. They may have to miss dinner with friends, because of nausea and vomiting. Many people who suffer from migraines have gotten relief from Dr. Phelts' treatments at our New York, NY office. Dr. Phelts uses chiropractic adjustments and applied kinesiology treatments, which seems to be the best combination for migraine relief.
Migraine headaches are part of a complex neurological condition that can encompass a variety of symptoms, including visual disturbances; nausea and/or vomiting; dizziness; extreme sensitivity to sound, light, touch, and smell; and tingling or numbness in the extremities or face.1
Chiropractic migraine research studies
A 2017 study included 104 patients who suffered from migraines with a frequency of at least 2x/month. The participants were divided into three groups:
1. Pharmaceutical treatment group.
2. Chiropractic treatment group
3. Placebo group.
The studies occurred over a period of three months. The subjects were followed up with at three, six, and 12 months after the studly ended.
All three groups from experienced a significant reduction in frequency of migraines from the begriming of the study to 3 months. )Whenever a placebo group experiences improvement, Dr. Phelts says, "faith works"). This reduction in frequency lasted through the 12 month follow-up for the chiropractic groups. The length of each migraine episode was more significantly reduce in the chiropractic group as opposed to the pharmaceutical group.
References
Migraine Fact Sheet. http://www.migraineresearchfoundation.org/fact-sheet.html. Accessed July 14, 2019.
Chaibi A, Benth JŠ, Tuchin PJ, Russell MB. Chiropractic spinal manipulative therapy for migraine: A three-armed, single-blinded, placebo, randomized controlled trial. European Journal of Neurology. 2017;24(1):143-153.